Amanta Healthcare Shares List At 7% Premium After Strong IPO
AI-Generated Summary
Amanta Healthcare Ltd. shares debuted on the stock market with a 7% premium after its Initial Public Offering (IPO) opened at Rs 135 on the NSE, above the Rs 126 IPO price. The Rs 126 crore IPO, consisting of a fresh issuance of 1 crore shares, was significantly oversubscribed 86 times overall, with strong interest across all investor categories. Proceeds from the IPO will primarily fund capital expenditure, including establishing new manufacturing lines for SteriPort and SVP at its Gujarat facility, allocating Rs 70 crore for construction and equipment, and Rs 30 crore for the SVP line. This strategic investment aims to expand the company's production capabilities.
In a nutshell
The strong market debut and substantial oversubscription indicate robust investor confidence in Amanta Healthcare's growth prospects within the pharmaceutical sector. The strategic allocation of IPO funds towards expanding manufacturing infrastructure suggests a clear path for the company to enhance its production capacity and market presence.
Source: NDTV Profit
